A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1999
09/23/1999	WO1999047664A1 The human mitochondrial proteolipid mp68 homolog gene: cbnaac01
09/23/1999	WO1999047663A1 Human h-beta 58 gene (cblalc05)
09/23/1999	WO1999047662A1 Staphylococcus aureus genes and polypeptides
09/23/1999	WO1999047660A1 Retroviral packaging cell line
09/23/1999	WO1999047658A1 The cytokine family member ef-7
09/23/1999	WO1999047655A2 Human nucleic acid fragments with heightened expression in normal breast tissue
09/23/1999	WO1999047653A1 Suicide gene therapy system for the treatment of brain tumours
09/23/1999	WO1999047652A2 Novel rnase-like protein and its use
09/23/1999	WO1999047641A1 Compositions and methods for gene-based vaccines to provoke t cell responses
09/23/1999	WO1999047639A2 Staphylococcus aureus genes and polypeptides
09/23/1999	WO1999047588A1 Production of microparticles
09/23/1999	WO1999047566A1 Synthetic peptides that enhance ldl uptake
09/23/1999	WO1999047565A1 Anti-inositolphosphoglycan monoclonal antibodies
09/23/1999	WO1999047564A1 Fas-associated polypeptides
09/23/1999	WO1999047563A2 Ribonucleotide polypeptides containing metal
09/23/1999	WO1999047562A1 Nephrin gene and protein
09/23/1999	WO1999047561A1 Ribonucleotide polypeptides containing metal
09/23/1999	WO1999047559A1 Isoform 1 of dimethylglycine dehydrogenase-like gene
09/23/1999	WO1999047558A2 T cell costimulatory proteins, sequences and uses thereof
09/23/1999	WO1999047556A2 Novel heparin-induced ccn-like molecules and uses therefor
09/23/1999	WO1999047554A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
09/23/1999	WO1999047551A1 Wf14573 or its salt, production thereof and use thereof
09/23/1999	WO1999047550A1 Novel matrix metalloproteinase inhibitors and down-regulators
09/23/1999	WO1999047549A1 PIPERAZINES AS INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (FBPase)
09/23/1999	WO1999047547A1 Cinnamic acid derivatives having cell adhesion modulating activity
09/23/1999	WO1999047546A1 Hydroxyproline derivatives
09/23/1999	WO1999047545A2 Inhibitors of caspases
09/23/1999	WO1999047544A1 nrdF
09/23/1999	WO1999047540A1 95 human secreted proteins
09/23/1999	WO1999047538A1 Cytokine receptor common gamma chain like
09/23/1999	WO1999047537A1 Staphylococcus aureus spo0j2: polynucleotide and protein
09/23/1999	WO1999047227A1 Removal of contaminants from biological products
09/23/1999	WO1999047179A1 COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN DELIVERY TO ANTIGEN PRESENTING CELLS $i(IN VIVO)
09/23/1999	WO1999047178A1 Novel complementing receptor-ligand pairs and adoptive immunotherapy using same
09/23/1999	WO1999047177A1 Gene therapy vector with osteocalcin promoter and genes for bone morphogenic proteins or growth factors
09/23/1999	WO1999047173A2 Carrier for in vivo delivery of a therapeutic agent
09/23/1999	WO1999047170A1 Preventives or remedies for inflammatory intestinal diseases containing as the active ingredient il-6 antagonists
09/23/1999	WO1999047169A1 Methods to provoke anti-cancer immune responses
09/23/1999	WO1999047161A1 Human appetite control by glucagon-like peptide receptor binding compounds
09/23/1999	WO1999047160A1 Stabilized aqueous peptide solutions
09/23/1999	WO1999047159A1 Use of vip analogues for preventing and treating brain damage in human babies
09/23/1999	WO1999047158A2 Therapeutic chemokine receptor antagonists
09/23/1999	WO1999047157A1 Use of il-10 to treat major depressive disorder
09/23/1999	WO1999047156A2 Compositions for modulating cell differentiation comprising a lipid and a morphogen
09/23/1999	WO1999047155A1 Preventives and/or remedies for sepsis
09/23/1999	WO1999047154A1 Dipeptide caspase inhibitors and the use thereof
09/23/1999	WO1999047153A2 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY rho GTPase FUNCTION INHIBITORS
09/23/1999	WO1999047152A2 Use of dipeptidyl peptidase (dpp4) of fibroblast activating protein alpha for suppressing the malignant phenotype of cancer cells
09/23/1999	WO1999047151A1 Peptide ligands for the erythropoietin receptor
09/23/1999	WO1999047150A2 A pharmaceutical composition containing ezrin mutated on tyrosine 353
09/23/1999	WO1999047147A1 nrdG
09/23/1999	WO1999047146A1 Anti-hiv combination comprising hydroxyurea, ddi, and a protease inhibitor
09/23/1999	WO1999047129A1 Crosslinkable macromers bearing initiator groups
09/23/1999	WO1999047097A2 Material composition for the formation of tissue
09/23/1999	WO1999047070A1 Improved implantable biomaterials, compositions and methods for their preparation and uses thereof
09/23/1999	WO1999046992A1 Induction of immunity against tumor self-antigens
09/23/1999	WO1999046991A1 Methods for treating hiv-associated dementia
09/23/1999	WO1999041374A3 Human short-chain tnf-receptor family protein
09/23/1999	WO1999041355A3 Hiv chemokines
09/23/1999	WO1999040112A8 Neuroprotective peptides and uses thereof
09/23/1999	WO1999040106A3 Use of angiotensin analogues for promoting erythropoiesis
09/23/1999	WO1999039740A8 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
09/23/1999	WO1999039736A3 DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES
09/23/1999	WO1999039728A3 Methods of inducing hair growth and coloration
09/23/1999	WO1999038955A3 Mutant herpes simplex viruses and uses thereof
09/23/1999	WO1999038524A3 Therapeutic administration of low density lipoprotein receptor for viral infections and immune regulation
09/23/1999	WO1999037774A8 Differentiation-associated sequences and methods of use therefor
09/23/1999	WO1999036570A3 Transglutaminase linkage of agents to tissue
09/23/1999	WO1999036533A3 Nucleic acid corresponding to mutation associated with cholestasis syndromes
09/23/1999	WO1999036517A3 Method for selecting ribozymes which are capable of covalently modifying the ribonucleic acids on 2'-oh-groups in trans
09/23/1999	WO1999036433A3 Materials and methods for treating oncological disease
09/23/1999	WO1999036100A3 Polymeric carrier
09/23/1999	WO1999036082A3 The use of increased neurofilament protein levels as protection and therapy against neurodegeneration with oxidative stress involvement
09/23/1999	WO1999033847A9 Phosphinic alkanoic acid derivatives
09/23/1999	WO1999032620A9 Insulin-like growth factor binding protein fragments and the utilization thereof
09/23/1999	WO1999032510A9 Kappa receptor opioid peptides
09/23/1999	WO1999030727A9 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
09/23/1999	WO1999029719A3 Pancreatic-derived factors, and uses related thereto
09/23/1999	WO1999028876A3 Hydrophobically-modified protein compositions and methods
09/23/1999	WO1999027944A9 Prevention and treatment of amyloidogenic disease
09/23/1999	WO1999025733A3 SUBSTANCES TARGETED TO THE ACTIVE SITE OF THE FtsH PROTEIN, DNA ENCODING SAID SUBSTANCES AND USES THEREOF
09/23/1999	DE19841413C1 New potassium channel protein, Kv6.2, used to screen for specific modulators, potentially useful e.g. as antiarrhythmic agents
09/23/1999	DE19825395C1 New antiviral RNA that binds specifically to a picorna virus protein, for preventing rhinovirus, polio and Coxsackie virus infections
09/23/1999	DE19813839A1 Human nucleic acid sequences and protein products from tumor breast tissue, useful for breast cancer therapy
09/23/1999	DE19813835A1 Human nucleic acid sequences and protein products from normal breast tissue, useful for breast cancer therapy
09/23/1999	DE19802139C1 Monoklonaler Antikörper spezifisch für aktivierten Gerinnungsfaktor VII und seine Verwendung A monoclonal antibody specific for activated coagulation factor VII and its use
09/23/1999	CA2625284A1 Modulators of the function of receptors of the tnf/ngf receptor family
09/23/1999	CA2403836A1 Dipeptide caspase inhibitors and the use thereof
09/23/1999	CA2324235A1 Production of microparticles
09/23/1999	CA2324138A1 Novel complementing receptor-ligand pairs and adoptive immunotherapy using same
09/23/1999	CA2323897A1 Suicide gene therapy system for the treatment of brain tumours
09/23/1999	CA2323808A1 Hydroxyproline derivatives
09/23/1999	CA2323784A1 Carrier for in vivo delivery of a therapeutic agent
09/23/1999	CA2323761A1 95 human secreted proteins
09/23/1999	CA2323746A1 T cell costimulatory proteins, sequences and uses thereof
09/23/1999	CA2323724A1 Staphylococcus aureus genes and polypeptides
09/23/1999	CA2323637A1 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
09/23/1999	CA2323604A1 Interferon alpha plasmids and delivery systems, and methods of making and using the same
09/23/1999	CA2323439A1 Dipeptide caspase inhibitors and the use thereof
09/23/1999	CA2323238A1 Methods and compositions for diagnosis of rheumatoid arthritis

1 ... 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 ... 3163